Discover how understanding your viral load and CD4 count puts you in control of HIV treatment and transforms confusing ...

Incomplete immune recovery despite sustained virologic suppression in patients with HIV was associated with increased risk for incident cancer.

HIV/AIDS remains a major public health threat worldwide, with an estimated 39.9 million people living with the disease at the end of 2023. Around 630,000 people died from illnesses related to AIDS the ...

The Johns Hopkins team that conducted the new study had previously shown that the molecule of interest, an “antisense ...

I experienced one of the most challenging episodes of my life.  I had just arrived home from work when the son of a close ...

There are two ways that HIV patients’ bodies can keep the virus under control after they stop antiretroviral therapy, a new ...

Gene therapy may be a crucial tool to put HIV to sleep permanently, providing a lasting and durable treatment against the v ...

HIV remains incurable but manageable. Johns Hopkins found a way to silence it long-term using a molecule from the virus ...

Antiretroviral therapy (ART) initiated in the acute phase of HIV infection (AHI) results in a smaller viral reservoir. However, the impact of early HIV-specific T-cell responses on long-term reservoir ...

Whether antiretroviral therapy (ART) is always completely suppressive, or HIV might continue to replicate at low levels despite ART in some people with HIV (PWH), is still debated. Here, we ...

A new nanozyme-powered TB test improves detection in people with HIV, offering rapid, electricity-free diagnosis via a beetle-inspired chip.

Gilead Sciences (NASDAQ:GILD) has demonstrated a strong performance this year, with its stock up 18% compared to the S&P ...